Relaxation and Guided Imagery Significantly Reduces Androgen Levels and Distress in Polycystic Ovary Syndrome: Pilot Study

AIM: Women with polycystic ovary syndrome (PCOS) often have elevated levels of the androgen testosterone, and are at increased risk of anxiety and depression. This study aimed to use psychological relaxation with guided imagery to decrease androgen levels and improve mood in PCOS. METHODS: Repeated-measures. Thirteen women with PCOS underwent six weekly treatment sessions, and a follow-up session, of calming breathing, muscle relaxation, and guided imagery. The main outcome measures were mood and quality of life (QoL) – assessed using validated questionnaires – and hormones, which were assayed in serum using tandem mass spectrometry. RESULTS: There was a small but statistically significant reduction in DHEAS from before to after Week 1 (p <.044) and from before to after Week 6 (p <.001). From before to after Week 6 there were also small but statistically significant reductions in androstenedione (p <.010) and cortisol (p <.003). From Week 1 to Week 6 there was a significant reduction in anxiety (p <.037). There was a significant improvement in depression from Week 1 to Week 6 (p <.034) and from Week 1 to follow-up (p <.011). There were no significant changes in free or total testosterone, nor in QoL. CONCLUSIONS: This is the first study to use a relaxation programme to reduce adrenal androgens in PCOS.